Morgan Stanley Maintains Equal-Weight on DexCom, Raises Price Target to $122
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Patrick Wood has maintained an Equal-Weight rating on DexCom (NASDAQ:DXCM) and increased the price target from $101 to $122.
December 04, 2023 | 3:49 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Morgan Stanley analyst Patrick Wood maintained an Equal-Weight rating on DexCom and raised the price target to $122, indicating a positive outlook on the stock.
The increase in price target by a reputable analyst like Patrick Wood from Morgan Stanley suggests a positive reassessment of DexCom's value, which could lead to increased investor confidence and a potential short-term rise in the stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100